Primary Site >> Esophagus Cancer
Gene >> CD4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma. PMID: 1372377 Ref: Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer. PMID: 1386555 |
Ref: HLA A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma. PMID: 7671230 Ref: [Tumor-rejection antigens expressed on human squamous cell carcinoma]. PMID: 8721083 |
Ref: Prognostic significance of immunological parameters in patients with esophageal cancer. PMID: 8799384 |
Ref: Effects of en bloc esophagectomy on nutritional and immune status in patients with esophageal carcinoma. PMID: 9486779 Ref: The influence of surgical stress on T cells: enhancement of early phase lymphocyte activation. PMID: 9842843 |
Ref: Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor. PMID: 10394145 |
Ref: Immunohistochemical study of leukocyte infiltration and expression of hsp70 in esophageal squamous cell carcinoma. PMID: 11295085 |
Ref: A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein. PMID: 12817001 Ref: [Influence of different doses of fentanyl on T-lymphocyte subpopulations and natural killer cells of patients with esophageal tumor during preoperation and postoperation]. PMID: 12948416 Ref: Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. PMID: 14555512 |
Ref: [Perioperative changes of cellular immune response of patients with esophageal carcinoma evaluated through detecting AgNOR content in peripheral blood T lymphocytes and T cell subsets]. PMID: 16004816 |
Ref: CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. PMID: 16328385 Ref: Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusion. PMID: 16362409 Ref: Lymphocytic esophagitis: a histologic subset of chronic esophagitis. PMID: 16613348 Ref: Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma. PMID: 16799337 |
Ref: T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. PMID: 17441676 Ref: [Effect of cellular immune supportive treatment on immunity of esophageal carcinoma patients after modern two-field lymph node dissection]. PMID: 17626759 |
Ref: Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination. PMID: 18729190 |
Ref: Inverse correlation between NKG2D expression on CD8+ T cells and the frequency of CD4+CD25+ regulatory T cells in patients with esophageal cancer. PMID: 18564160 Ref: Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer. PMID: 19307989 Ref: Tumor immune systems in esophageal cancer with special reference to heat-shock protein 70 and humoral immunity. PMID: 19443372 Ref: Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer. PMID: 19632080 |
Ref: Primary esophageal carcinoma in the era of highly active antiretroviral therapy. PMID: 20101017 Ref: [Effects of different anesthetic and analgesic protocols on cellular immune function and stress hormone level in patients undergoing lobectomy for esophagus cancer]. PMID: 20159701 |
Ref: Localization of IL-17+Foxp3+ T cells in esophageal cancer. PMID: 21314287 Ref: A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. PMID: 21448901 Ref: CD4 + CD25high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy. PMID: 21607687 Ref: Prognostic significance of heat shock protein 110 expression and T lymphocyte infiltration in esophageal cancer. PMID: 22086686 |
Ref: Effects of an immuno-enhanced diet containing antioxidants in esophageal cancer surgery following neoadjuvant therapy. PMID: 21762279 Ref: The immunological impact of neoadjuvant chemotherapy on the tumor microenvironment of esophageal squamous cell carcinoma. PMID: 21822560 Ref: Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer. PMID: 22082565 Ref: Correlation between circulating myeloid-derived suppressor cells and Th17 cells in esophageal cancer. PMID: 23082063 |
Ref: Correlation between the CD4+CD25high regulatory T cells and the outcome of chemotherapy in advanced esophageal carcinoma. PMID: 23262265 Ref: Fish oil-supplemented parenteral nutrition in patients following esophageal cancer surgery: effect on inflammation and immune function. PMID: 23368915 Ref: Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes. PMID: 23436617 Ref: Preventive effect of ulinastatin on postoperative complications, immunosuppression, and recurrence in esophagectomy patients. PMID: 23575450 Ref: Effect of early enteral nutrition on postoperative nutritional status and immune function in elderly patients with esophageal cancer or cardiac cancer. PMID: 23825906 |
Ref: Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma. PMID: 24249528 Ref: Randomized study of antiinflammatory and immune-modulatory effects of enteral immunonutrition during concurrent chemoradiotherapy for esophageal cancer. PMID: 24274379 Ref: Production of NY-ESO-1 peptide/DRB1*08:03 tetramers and ex vivo detection of CD4 T-cell responses in vaccinated cancer patients. PMID: 24397899 Ref: [Effect of early enteral nutrition on immune response and clinical outcomes after esophageal cancer surgery]. PMID: 24760645 Ref: Investigation on immune function and chest drainage in patients with thoracic malignancies using the streptococcal agent Sapylin. PMID: 25579549 |
Ref: Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial. PMID: 25575640 Ref: Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients. PMID: 26429981 |
Ref: Comparison of postoperative immune function in patients with thoracic esophageal cancer after video-assisted thoracoscopic surgery or conventional open esophagectomy. PMID: 27174507 Ref: Fast-track surgery improves postoperative clinical recovery and cellular and humoral immunity after esophagectomy for esophageal cancer. PMID: 27401305 Ref: THE EFFECTS OF A SIMPLE METHOD FOR CRYOPRESERVATION AND THAWING PROCEDURES ON CORD BLOOD DERIVED DC-BASED ESOPHAGEAL CARCINOMA VACCINE. PMID: 27925010 Ref: Ecrg4 contributes to the anti-glioma immunosurveillance through type-I interferon signaling. PMID: 28123880 Ref: Foxp3+ lymphocyte count in Barrett's esophagus tissue is higher than in in amed esophageal tissue. PMID: 28275271 |
Ref: Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer. PMID: 28084319 Ref: Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis. PMID: 28408841 Ref: Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3. PMID: 28809608 Ref: Effects of preemptive analgesia with flurbiprofen ester on lymphocytes and natural killer cells in patients undergoing esophagectomy: A randomized controlled pilot study. PMID: 28892265 |
Ref: Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis. PMID: 29414812 Ref: Tocopherols inhibit esophageal carcinogenesis through attenuating NF-kappaB activation and CXCR3-mediated inflammation. PMID: 29662196 Ref: Esophagectomy in Patients with Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome: A Viable Option. PMID: 29747950 |